Cargando…
Galantamine improves glycemic control and diabetic nephropathy in Lepr(db/db) mice
Galantamine, a centrally acting acetylcholinesterase inhibitor, has been shown to attenuate inflammation and insulin resistance in patients with metabolic syndrome. We investigated the effects of galantamine on glycemic control and development of diabetic nephropathy (DN) in Lepr(db/db) mice. Galant...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511534/ https://www.ncbi.nlm.nih.gov/pubmed/37731032 http://dx.doi.org/10.1038/s41598-023-42665-2 |